Skip to main content

Table 3 Analysis of factors associated with SARS-CoV-2 infection in the study participants (logistic regression)

From: SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional study

 

Participants

Anti-N positive

OR [95% CI]

p-value(1)

aOR [95% IC]

p-value(2)

n

n (%)

    

Total

1,120

503 (44.9)

    

Month of inclusion

   

 < 0.001

 

 < 0.001

 April

72

20 (27.8)

0.49 [0.28–0.88]

 

0.49 [0.26–0.93]

 

 May

212

41 (19.3)

0.31 [0.20–0.47]

 

0.35 [0.23–0.55]

 

 June

195

44 (22.6)

0.37 [0.24–0.57]

 

0.42 [0.27–0.65]

 

 July

230

101 (43.9)

1 (Ref.)

 

1 (Ref.)

 

 October

247

176 (71.3)

3.17 [2.17–4.63]

 

4.87 [3.21- 7.37]

 

 November

146

112 (76.7)

4.21 [2.65–6.69]

 

7.17 [4.28–12.00]

 

 December

18

9 (50.0)

1.28 [0.49–3.34]

 

2.56 [0.90–7.23]

 

Archipelago

   

 < 0.001

  

 Society (WIs)

641

398 (62.1)

1 (Ref.)

   

 Society (LIs)

103

28 (27.2)

0.23 [0.14–0.36]

   

 Austral

59

14 (23.7)

0.19 [0.10–0.35]

   

 Marquesas

217

42 (19.4)

0.15 [0.10–0.21]

   

 Tuamotu

59

10 (17.0)

0.12 [0.06–0.25]

   

 Gambier

41

11 (26.8)

0.22 [0.11–0.45]

   

Island

   

 < 0.001

  

Society (WIs)

 Tahiti

593

367 (61.9)

1 (Ref.)

   

 Moorea

48

31 (64.6)

1.12 [0.61–2.08]

   

Society (LIs)

 Bora Bora

42

16 (38.1)

0.38 [0.20–0.72]

   

 Huahine

61

12 (19.7)

0.15 [0.08–0.29]

   

Austral

 Rimatara

19

1 (5.3)

0.03 [0.00–0.26]

   

 Raivavae

40

13 (32.5)

0.30 [0.15–0.59]

   

Marquesas

 Nuku Hiva

101

19 (18.8)

0.14 [0.08–0.24]

   

 Hiva Oa

63

9 (14.3)

0.10 [0.05–0.21]

   

 Ua Pou

53

14 (26.4)

0.22 [0.12–0.42]

   

Tuamotu

 Fakarava

32

7 (21.9)

0.17 [0.07–0.41]

   

 Hao

27

3 (11.1)

0.08 [0.02–0.26]

   

Gambier

 Mangareva

41

11 (26.8)

0.23 [0.11–0.46]

   

INSEE classification of municipalities

  

 < 0.001

  

 Rural area

709

278 (39.2)

0.53 [0.42–0.68]

   

 Urban area

411

225 (54.7)

1 (Ref.)

   

Gender

   

0.57

 

0.02

 Male

536

236 (44.0)

0.93 [0.74–1.18]

 

0.71 [0.53–0.95]

 

 Female

584

267 (45.7)

1 (Ref.)

 

1 (Ref.)

 

Age range (in years)

   

0.02

  

 18–29

337

169 (50.1)

1.22 [0.92–1.64]

   

 30–44

408

184 (45.1)

1 (Ref.)

   

 45–69

375

150 (40.0)

0.81 [0.61–1.08]

   

Socio-cultural background

   

0.41

  

 Polynesian

841

385 (45.8)

1 (Ref.)

   

 Caucasian

53

19 (35.8)

0.66 [0.37–1.18]

   

 Asian

10

2 (20.0)

0.30 [0.06–1.40]

   

 Mixed race

200

90 (45.0)

0.97 [0.71–1.32]

   

 Other

8

4 (50.0)

1.18 [0.29–4.77]

   

Level of education

   

0.94

  

 Primary school (or before)

164

70 (42.7)

0.92 [0.64–1.32]

   

 Secondary school

276

126 (45.7)

1.03 [0.76–1.40]

   

 High school (or equivalent)

433

194 (44.8)

1 (Ref.)

   

 University or after

246

113 (45.9)

1.05 [0.76–1.43]

   

 Missing data

1

0 (0.0)

0.41 [0.02–10.13]

   

Marital statusa

   

0.05

 

0.01

 Never married

292

112 (38.4)

0.71 [0.54–0.94]

 

0.64 [0.46–0.89]

 

 In a relationship

756

353 (46.7)

1 (Ref.)

 

1 (Ref.)

 

 Separated, divorced, widowed

70

37 (52.9)

1.28 [0.78–2.09]

 

1.69 [0.96–2.97]

 

 Missing data

2

1 (50.0)

1.14 [0.07–18.32]

 

0.61 [0.03–11.92]

 

Professional occupation

   

 < 0.001

  

 Government employee

173

63 (36.4)

0.52 [0.35–0.76]

   

 Private employee (and volunteers)

272

143 (52.6)

1 (Ref.)

   

 Self-employed

184

62 (33.7)

0.46 [0.31–0.68]

   

 Student

40

21 (52.5)

1.00 [0.51–1.94]

   

 No outside activity

451

214 (47.5)

0.81 [0.60–1.10]

   

Number of people in the household

   

 < 0.001

  

 1–2

229

80 (34.9)

0.63 [0.46–0.86]

   

 3–5

609

281 (46.1)

1 (Ref.)

   

 6–10

248

119 (48.0)

1.08 [0.80–1.45]

   

  ≥ 11

34

23 (67.6)

2.44 [1.17–5.09]

   

Body Mass Index (kg/m2)

   

0.60

  

  < 25

222

95 (42.8)

1 (Ref.)

   

 25–29

290

128 (44.1)

1.06 [0.74–1.50]

   

  ≥ 30

598

277 (46.3)

1.15 [0.85–1.57]

   

 Missing data

10

3 (30.0)

0.57 [0.14–2.27]

   

High blood pressureb

   

0.05

  

 No

714

340 (47.6)

1 (Ref.)

   

 Yes

405

163 (40.2)

0.74 [0.58–0.95]

   

 Missing data

1

0 (0.0)

0.37 [0.01–9.03]

   

Diabetesc

   

0.31

  

 No

1018

464 (45.6)

1 (Ref.)

   

 Yes

91

34 (37.4)

0.71 [0.46–1.11]

   

 Missing data

11

5 (45.5)

0.99 [0.30–3.28]

   

Respiratory allergyd

   

0.47

 

0.03

 Yes

99

41 (41.4)

0.86 [0.57–1.31]

 

0.54 [0.33–0.89]

 

 No

1013

457 (45.1)

1 (Ref.)

 

1 (Ref.)

 

 Missing data

8

5 (62.5)

2.03 [0.48–8.53]

 

2.46 [0.45–13.60]

 

Asthmad

   

0.35

  

 Yes

212

99 (46.7)

1.08 [0.80–1.46]

   

 No

904

404 (44.7)

1 (Ref.)

   

 Missing data

4

0 (0.0)

0.14 [0.01–2.56]

   

Long-term illness

   

0.62

  

 Yes

176

76 (43.2)

0.92 [0.67–1.27]

   

 No

944

427 (45.2)

1 (Ref.)

   

History of cancer

   

0.25

  

 Yes

32

11 (34.4)

0.64 [0.31–1.33]

   

 No

1085

492 (45.3)

1 (Ref.)

   

 Missing data

3

0 (0.0)

0.17 [0.01–3.34]

   

Level of physical activitye

   

0.95

  

 Limited

347

160 (46.1)

1.05 [0.75–1.46]

   

 Moderate

240

108 (45.0)

1 (Ref.)

   

 High

531

234 (44.1)

0.96 [0.71–1.31]

   

 Missing data

2

1 (50.0)

1.22 [0.08–19.77]

   

Smoking

   

0.03

 

0.04

 Yes

455

187 (41.1)

0.77 [0.61–0.98]

 

0.74 [0.56–0.98]

 

 No

665

316 (47.5)

1 (Ref.)

 

1 (Ref.)

 

Preventive measure: Hand hygiene

0.06

  

 No

135

48 (35.6)

1 (Ref.)

   

 Yes

984

455 (46.2)

1.55 [1.07–2.25]

   

 Missing data

1

0 (0.0)

0.60 [0.02–15.05]

   

Preventive measure: Not shaking hands

0.07

  

 No

350

140 (40.0)

1 (Ref.)

   

 Yes

769

363 (47.2)

1.34 [1.04–1.73]

   

 Missing data

1

0 (0.0)

0.50 [0.02–12.35]

   

Preventive measure: Coughing into the elbow

0.01

  

 No

494

197 (39.9)

1 (Ref.)

   

 Yes

625

306 (49.0)

1.45 [1.14–1.83]

   

Missing data

1

0 (0.0)

0.50 [0.02–12.39]

   

Preventive measure: Physical distancing

 < 0.001

  

 No

309

111 (35.9)

1 (Ref.)

   

 Yes

810

392 (48.4)

1.67 [1.27–2.19]

   

 Missing data

1

0 (0.0)

0.59 [0.02–14.69]

   

Preventive measure: Wearing mask

0.83

  

 No

83

36 (43.4)

1 (Ref.)

   

 Yes

1036

467 (45.1)

1.07 [0.68–1.67]

   

 Missing data

1

0 (0.0)

0.43 [0.02–10.96]

   

Vaccination status before SARS-CoV-2 infection (if any)

 < 0.001

 

 < 0.001

 Not vaccinated

645

325 (50.4)

1 (Ref.)

 

1 (Ref.)

 

 Vaccinated

441

170 (38.5)

0.62 [0.48–0.79]

 

0.38 [0.28–0.52]

 

 Missing data

34

8 (23.5)

0.30 [0.14–0.68]

 

0.82 [0.33–2.06]

 
  1. OR Odds ratio, aOR Adjusted odds ratio, CI Confidence interval, INSEE Institut National de la Statistique et des Etudes Economiques (https://www.insee.fr/fr/statistiques/3651609)
  2. (1) Likelihood-ratio test
  3. (2) Wald test
  4. a'Never married' excludes cohabiting participants and ‘In a relationship’ includes married and cohabiting participants
  5. bHigh blood pressure was defined as systolic blood pressure of 140 mmHg or higher, or diastolic blood pressure of 90 mmHg or higher, or taking blood pressure medication in the last two weeks (self-reported)
  6. cDiabetes was defined as a glycated hemoglobin of 6.5% or above or taking antidiabetic medication in the last two weeks (self-reported)
  7. dRespiratory allergy and asthma were declarative variables in response to the respective questions "Has a doctor or other health professional ever told you that you have known respiratory allergies (dust, pollen, animals)?" and "Has a doctor or other health professional ever told you that you have asthma?"
  8. eLevel of physical activity was defined according to WHO criteria